体外生命支持在成人危重症中的获益机制:呼吸与心脏衰竭
本文综述体外生命支持(ECLS)在成人严重呼吸和/或心脏衰竭中的生理获益机制。ECLS通过恢复气体交换、优化循环动力学和减轻继发性器官损伤,为组织修复和辅助治疗创造条件;在呼吸衰竭中可稳定气体交换并调节呼吸驱动,在心源性休克中恢复灌注并可能降低心肌氧耗,在心脏骤停中可能提供神经保护。优化患者选择、启动时机和辅助治疗需理解这些生理通路间的相互作用,并权衡装置相关并发症等限制。
要点
- ECLS通过恢复气体交换、优化循环和减轻继发器官损伤发挥获益。
- 呼吸ECLS可稳定气体交换、调节呼吸驱动,助力肺保护性通气。
- 心脏ECLS恢复灌注并可能降低心肌氧耗,心脏骤停时或有神经保护。
核心结论
- ECLS通过恢复气体交换、优化循环动力学和减轻继发性器官损伤,为组织修复和辅助治疗创造条件。
- 在呼吸衰竭中,呼吸ECLS稳定气体交换并调节呼吸驱动,可能减轻呼吸机相关和患者自致肺损伤。
- 在心源性休克中,心脏ECLS恢复全身灌注并可能降低心肌氧耗;在心脏骤停中可能提供神经保护。
研究设计与样本
- 本文为State-of-the-Art综述,综合当前文献探讨ECLS在成人危重症中的机制基础。
主要发现
- 在孤立性呼吸衰竭中,呼吸ECLS稳定气体交换并调节呼吸驱动,实现肺保护性通气。
- 在心源性休克中,心脏ECLS恢复全身灌注并可能降低心肌氧耗。
- 在心脏骤停中,ECLS可能提供神经保护效应。
- 在合并心肺衰竭中,高级ECLS模式可增强体循环和肺循环,支持气体交换并维持终末器官灌注。
- 机制上,这些干预中断低氧血症和/或高碳酸血症诱导的肺血管收缩、右心室过负荷和全身低灌注的级联反应,促进多器官恢复。
临床怎么用
- 优化患者选择、ECLS启动时机和辅助治疗需细致理解生理通路间的相互作用。
- 需谨慎考虑装置相关并发症、血液学和炎症扰动以及生理权衡等关键限制。
局限性
- ECLS的生理获益机制尚未完全明确。
- 需考虑装置相关并发症、血液学和炎症扰动以及生理权衡等限制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Extracorporeal life support provides temporary cardiorespiratory support for patients with severe, potentially reversible cardiac and/or respiratory failure refractory to conventional measures. Its application has broadened across a wide spectrum of critical illness, yet the mechanistic basis of its physiologic benefit remains incompletely defined. This review explores the mechanisms through which extracorporeal life support may confer benefit in respiratory and cardiac failure. These include restoration of gas exchange, optimization of circulatory dynamics, and mitigation of secondary organ injuries, creating conditions that facilitate tissue repair, enable adjunctive therapies, and, in selected cases, provide a bridge to transplantation. In isolated respiratory failure, respiratory extracorporeal life support stabilizes gas exchange and modulates respiratory drive, enabling lung-protective ventilation and potentially attenuating ventilator- and patient self-inflicted lung injury. In cardiogenic shock, cardiac extracorporeal life support restores systemic perfusion and may reduce myocardial oxygen demand, while during cardiac arrest, it may confer neuroprotective effects. In combined cardiorespiratory failure, advanced extracorporeal support modalities may augment both systemic and pulmonary circulation, supporting gas exchange and maintaining end-organ perfusion. Mechanistically, these interventions interrupt the cascade of hypoxemia- and/or hypercapnia- induced pulmonary vasoconstriction, right ventricular overload, and systemic hypoperfusion, facilitating multiorgan recovery. Optimizing patient selection, timing for extracorporeal life support initiation, and use of adjunctive therapies require a nuanced understanding of the interplay between these physiologic pathways alongside careful considerations of key limitations, including device-related complications, hematologic and inflammatory perturbations, and physiologic trade-offs. This State-of-the-Art review synthesizes the current literature on the mechanistic basis of extracorporeal life support in adults.
引用
- Zochios V, Brewer JM, Antonini MV, et al. Extracorporeal life support in adult critically ill patients: mechanisms of benefit in respiratory and cardiac failure. Am J Respir Crit Care Med. 2026. PMID: 42320025. doi:10.1093/ajrccm/aamag321
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。